Harvard Bioscience, Inc. (HBIO) key performance indicators and operating metrics (5 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization Margin | 3.70 percent | FY2026-Q1 |
| Adjusted Operating Margin (Non-GAAP) | 1.10 percent | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 3.8M | FY2025-Q4 |
| Adjusted Operating Income (Non-GAAP) | 3.28M | FY2025-Q4 |
| Diluted Adjusted Earnings Per Share (Non-GAAP) | -0.01 USD_per_share | FY2025-Q2 |
Back to HBIO overview · HBIO earnings · HBIO holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.